APVO Logo

Aptevo Therapeutics Inc. (APVO) 

NASDAQ$2.46+0.08 (3.36%)
Market Cap
$3.47M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
456 of 924
Rank in Industry
267 of 527

APVO Insider Trading Activity

APVO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a â€¦

Insider Activity of Aptevo Therapeutics Inc.

Over the last 12 months, insiders at Aptevo Therapeutics Inc. have bought $0 and sold $0 worth of Aptevo Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Aptevo Therapeutics Inc. have bought $49.69M and sold $16.87M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 348,554 shares for transaction amount of $7.92M was made by TANG KEVIN C (10 percent owner) on 2020‑11‑06.

List of Insider Buy and Sell Transactions, Aptevo Therapeutics Inc.

2021-11-23SaleTANG KEVIN C
921,336
12.987%
$11.25$10.37M-73.69%
2021-11-22SaleTANG KEVIN C10 percent owner
255,331
5.9122%
$7.03$1.8M-30.86%
2021-11-19SaleTANG KEVIN C10 percent owner
213,800
4.7422%
$7.59$1.62M-38.63%
2021-11-18SaleTANG KEVIN C10 percent owner
369,533
8.1153%
$8.34$3.08M-44.69%
2020-11-06PurchaseTANG KEVIN C10 percent owner
348,554
7.5668%
$22.73$7.92M+8.23%
2020-11-05PurchaseTANG KEVIN C10 percent owner
1.25M
25.0765%
$18.78$23.5M+20.82%
2020-11-04PurchaseTANG KEVIN C10 percent owner
1.27M
24.3464%
$14.34$18.27M+50.91%
2019-08-16PurchaseMaddux Randy JoeSVP Operations, CMO
50,000
0.1097%
$0.76$38,000-25.67%
2019-08-12PurchaseEl-Hibri Fuaddirector
200,000
0.4342%
$0.76$151,040-25.24%
2019-07-29PurchaseEl-Hibri FuadBoard of Directors
110,030
0.2409%
$0.83$91,721-31.45%
2019-07-23PurchaseEl-Hibri FuadBoard of Directors
20,000
0.0452%
$0.90$17,992-34.35%
2019-07-22PurchaseEl-Hibri FuadBoard of Directors
60,000
0.1331%
$0.89$53,202-34.06%
2019-07-19PurchaseEl-Hibri FuadBoard of Directors
52,920
0.1212%
$0.90$47,480-33.33%
2019-07-18PurchaseEl-Hibri FuadBoard of Directors
28,808
0.0638%
$0.87$25,193-33.40%
2019-07-17PurchaseEl-Hibri FuadBoard of Directors
38,272
0.085%
$0.87$33,408-32.68%
2019-07-16PurchaseEl-Hibri FuadBoard of Directors
22,750
0.0486%
$0.85$19,324-33.41%
2019-07-11PurchaseEl-Hibri FuadBoard of Directors
29,382
0.0649%
$0.85$24,907-30.51%
2019-07-10PurchaseEl-Hibri Fuaddirector
37,838
0.0843%
$0.85$32,117-30.01%
2019-06-25PurchaseAbdun-Nabi DanielBoard of Directors
33,334
0.0753%
$0.90$30,001-33.16%
2019-06-14PurchaseWhite Marvin LPresident and CEO
100,000
0.2219%
$0.88$88,000-30.63%
Total: 32

APVO Institutional Investors: Active Positions

Increased Positions11+64.71%45,930+132.41%
Decreased Positions8-47.06%32,082-92.49%
New Positions4New4,969New
Sold Out Positions8Sold Out32,082Sold Out
Total Postitions20+17.65%48,535+39.92%

APVO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Virtu Financial Llc$83.002.16%21,627+20,493+1,807.14%2024-12-31
Hrt Financial Lp$47.001.23%12,324+11,564+1,521.58%2024-12-31
Jpmorgan Chase & Co$17.000.45%4,529+4,528+452,800%2024-12-31
Diadema Partners Lp$15.000.41%4,050+4,050New2024-12-31
Morgan Stanley$15.000.39%3,927+3,922+78,440%2024-12-31
Tower Research Capital Llc (Trc)$4.000.11%1,086+408+60.18%2024-12-31
Ubs Group Ag$3.000.08%783+783New2024-12-31
Sbi Securities Co., Ltd.$1.000.01%131+131New2024-12-31
Osaic Holdings, Inc.$00.01%45+44+4,400%2024-12-31
Blackrock, Inc.$0<0.01%2400%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.